Eli Lilly and Co (LTS:0Q1G) Cyclically Adjusted Book per Share: CHF (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0Q1G Eli Lilly and Co LTS:0Q1G
87 GF Score
Price CHF1,020.00
GF Value CHF882.28
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Eli Lilly and Co Cyclically Adjusted Book per Share?

Eli Lilly and Co LTS:0Q1G 87 Cyclically Adjusted Book per Share is CHF as of Jun. 2026. GuruFocus rates LTS:0Q1G with a GF Score™ of 87/100 and a GF Value™ of CHF882.28 (Modestly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Eli Lilly and Co's adjusted book value per share for the three months ended in Jun. 2026 was CHF29.027. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is CHF for the trailing ten years ended in Jun. 2026.

During the past 12 months, Eli Lilly and Co's average Cyclically Adjusted Book Growth Rate was 14.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 1.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 0.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -0.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Eli Lilly and Co was 8.80% per year. The lowest was -2.00% per year. And the median was 3.70% per year.

As of today (2026-09-20), Eli Lilly and Co's current stock price is CHF1020.00. Eli Lilly and Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was CHF. Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 87.86. The lowest was 5.24. And the median was 19.24.


Eli Lilly and Co  (LTS:0Q1G) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 87.86. The lowest was 5.24. And the median was 19.24.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Eli Lilly and Co Cyclically Adjusted Book per Share Related Terms


Eli Lilly and Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Cyclically Adjusted Book per Share Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Eli Lilly and Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

LTS:0Q1G vs JNJ, ABBV, MRK: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Cyclically Adjusted PB Ratio falls into.


LTS:0Q1G
87GF Score
Eli Lilly and Co LTS:0Q1G
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=29.027/333.9520*333.9520
=29.027

Current CPI (Jun. 2026) = 333.9520.

Eli Lilly and Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 13.713 241.428 18.968
201612 12.999 241.432 17.980
201703 12.794 243.801 17.525
201706 12.325 244.955 16.803
201709 13.147 246.819 17.788
201712 10.337 246.524 14.003
201803 12.870 249.554 17.223
201806 10.744 251.989 14.239
201809 13.049 252.439 17.263
201812 10.174 251.233 13.524
201903 2.630 254.202 3.455
201906 2.884 256.143 3.760
201909 3.594 256.759 4.675
201912 2.730 256.974 3.548
202003 3.234 258.115 4.184
202006 4.230 257.797 5.480
202009 4.796 260.280 6.154
202012 5.383 260.474 6.902
202103 6.964 264.877 8.780
202106 6.436 271.696 7.911
202109 7.753 274.310 9.439
202112 8.747 278.802 10.477
202203 9.160 287.504 10.640
202206 8.721 296.311 9.829
202209 10.525 296.808 11.842
202212 10.492 296.797 11.805
202303 10.865 301.836 12.021
202306 10.503 305.109 11.496
202309 10.892 307.789 11.818
202312 9.631 306.746 10.485
202403 12.223 312.332 13.069
202406 12.887 314.175 13.698
202409 12.713 315.301 13.465
202412 13.650 315.605 14.444
202503 14.788 319.799 15.442
202506 15.426 322.561 15.971
202509 20.064 324.800 20.629
202512 22.251 324.054 22.931
202603 26.570 330.213 26.871
202606 29.027 333.952 29.027

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of CHF mean?
Eli Lilly and Co (LTS:0Q1G) has a Cyclically Adjusted Book per Share of CHF as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Eli Lilly and Co and its competitors.
Is Eli Lilly and Co's Cyclically Adjusted Book per Share too high?
Eli Lilly and Co's current Cyclically Adjusted Book per Share is CHF. Overall, Eli Lilly and Co has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's Cyclically Adjusted Book per Share compare to JNJ and ABBV?
Eli Lilly and Co's Cyclically Adjusted Book per Share of CHF can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Eli Lilly and Co and its competitors. Eli Lilly and Co's current Cyclically Adjusted Book per Share is CHF. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Based on GuruFocus' analysis, Eli Lilly and Co (LTS:0Q1G) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF882.28, compared to a current price of CHF1,020.00 — trading 15.6% above its estimated fair value. The current Cyclically Adjusted Book per Share is CHF. Eli Lilly and Co's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Eli Lilly and Co (LTS:0Q1G), the current Cyclically Adjusted Book per Share is CHF as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eli Lilly and Co (LTS:0Q1G) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be overvalued. The current stock price of CHF1,020.00 is trading 15.6% above its estimated GF Value™ of CHF882.28. GuruFocus considers Eli Lilly and Co to be Modestly Overvalued.

Key valuation signals for LTS:0Q1G:

  • Cyclically Adjusted Book per Share: CHF
  • GF Value™: CHF882.28 vs. price of CHF1,020.00 (15.6% above fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the LTS:0Q1G stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
87GF Score

Get the complete analysis for LTS:0Q1G

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF1,020.00
Price
CHF882.28
GF Value